Tauns Laboratories (TSE:197A) Other Stockholders Equity: 円36 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:197A Tauns Laboratories Inc TSE:197A
15 GF Score
Price 円473.00
! 6 Warning Signs
View Full Analysis

What is Tauns Laboratories Other Stockholders Equity?

Tauns Laboratories TSE:197A -0.63% 15 Other Stockholders Equity is 円36 Mil as of Dec. 2025. GuruFocus rates TSE:197A with a GF Score™ of 15/100. The stock has 6 warning signs investors should review.

Tauns Laboratories's Other Stockholders Equity for the quarter that ended in Dec. 2025 was 円36 Mil.

Tauns Laboratories's quarterly Other Stockholders Equity declined from Jun. 2025 (円1,187 Mil) to Sep. 2025 (円43 Mil) and declined from Sep. 2025 (円43 Mil) to Dec. 2025 (円36 Mil).

Tauns Laboratories's annual Other Stockholders Equity increased from Jun. 2023 (円28 Mil) to Jun. 2024 (円56 Mil) and increased from Jun. 2024 (円56 Mil) to Jun. 2025 (円1,187 Mil).

Tauns Laboratories Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Tauns Laboratories's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories Other Stockholders Equity Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Other Stockholders Equity
29.10 27.81 55.61 1,187.04

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 129.38 1,187.04 42.75 36.13 42.65
TSE:197A
15GF Score
Tauns Laboratories Inc TSE:197A
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tauns Laboratories Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of 円36 Mil mean?
Tauns Laboratories (TSE:197A) has a Other Stockholders Equity of 円36 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Tauns Laboratories and its competitors.
Is Tauns Laboratories' Other Stockholders Equity too high?
Tauns Laboratories' current Other Stockholders Equity is 円36 Mil. Overall, Tauns Laboratories has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' Other Stockholders Equity compare to ISRG and BDX?
Tauns Laboratories' Other Stockholders Equity of 円36 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Tauns Laboratories and its competitors. Tauns Laboratories's current Other Stockholders Equity is 円36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current Other Stockholders Equity of 円36 Mil. The current Other Stockholders Equity is 円36 Mil. Tauns Laboratories' overall GF Score™ is 15/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current Other Stockholders Equity is 円36 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tauns Laboratories Business Description

Address 761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
15GF Score

Get the complete analysis for TSE:197A

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円473.00
Price